arcadia

NATCO PHARMA LTD.

NSE : NATCOPHARMBSE : 524816ISIN CODE : INE987B01026Industry : Pharmaceuticals & DrugsHouse : Natco
BSE570.35-3.2 (-0.56 %)
PREV CLOSE ( ) 573.55
OPEN PRICE ( ) 579.50
BID PRICE (QTY) 570.35 (99)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 7788
TODAY'S LOW / HIGH ( )565.00 580.00
52 WK LOW / HIGH ( )568 849
NSE569.80-5.35 (-0.93 %)
PREV CLOSE( ) 575.15
OPEN PRICE ( ) 581.70
BID PRICE (QTY) 569.80 (74)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 127545
TODAY'S LOW / HIGH( ) 566.00 581.75
52 WK LOW / HIGH ( )568.6 848.3
1D 1M 3M 1Y 3Y 5Y
STOCK SUMMARY
Incorporation Year : 19-09 1981
Management Info
V C Nannapaneni - Chairman V C Nannapaneni - Managing Director
Registered Office

Address Natco House,Road No 2,Banjara Hills,
Hyderabad,
Telangana-500003

Phone 040-23547532

Email investors@natcopharma.co.in / dasaradhi@natcopharma.co.in

Website www.natcopharma.co.in

Registrars Details
Venture Capital & Corporate Investments Ltd
12-10-167,,MIG- 167,,Bharat Nagar Colony,Hyderabad
Listing : BSE, NSE, MCX
NEWS
18Feb Natco Pharma informs about investor pr
Natco Pharma has informed about submission of the Investor Presentation..
31Jan NATCO, Alvogen file ANDA for Ibrutinib
Natco Pharma and Alvogen Pine Brook LLC, USA, have submitted Abbreviated..
31Jan Natco Pharma gains on the bourses
Natco Pharma is currently trading at Rs. 683.70, up by 6.40 points or 0...
31Jan Natco Pharma informs about press release
Natco Pharma has informed about submission of the Press Release titled,..
28Jan Natco Pharma launches Valsartan-Sacubi
Natco Pharma has launched Valsartan-Sacubitril tablet at an affordable p..
Financials
Rs. in Millions
QTR Dec 18 ANNUAL 18
Net Profit16206982
Gross Profit 2064 8876
Operating Profit 23419678
Net Sales 531921085
ROLLING FORWARD P/E (EOD)
EVENT CALENDAR
peer group
Fredun Pharma (BSE)
 361.90 (9.70%)
M.Cap ( in Cr)144.38
Themis Medicare (BSE)
 305.00 (8.73%)
M.Cap ( in Cr)280.02
Everest Organics (BSE)
 157.65 (16.86%)
M.Cap ( in Cr)126.12
Pfizer (BSE)
 2907.45 (0.58%)
M.Cap ( in Cr)13300.92
Jenburkt Pharma (BSE)
 474.90 (3.28%)
M.Cap ( in Cr)217.95
Shareholding Pattern
PROMOTERS 48.42%
NON-INSTITUTION 21.67%
MUTUAL FUNDS/UTI 5.13%
FI/BANKS/INSURANCE 0.7%
GOVERNMENT 0%
FII 0%
Attention Investors

"KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary."

"Prevent Unauthorized Transactions in your demat account -> Update your Mobile Number and Email address with your Depository Participant. Receive alerts on your Registered Mobile and Email address for all debit and other important transactions in your demat account directly from CDSL on the same day..... issued in the interest of investors."

"No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account."

ARCADIA SHARE & STOCK BROKERS PVT. LTD.

MEMBER NSE (CASH & DERIVATIVES) : INB/F_230778238

MEMBER BSE (CASH) : INB010778232

MEMBER CDSL DP : IN225

ARCADIA COMMODITIES & TRADING

MEMBER MCX : 10950

MEMBER NCDEX : 00374 & FMC – MCX/TCM/PART/0503 & FMC –NCDEX/TCM/PART/0356 & ACE COMMODITY EXCHANGE MEMBER ID –

6090 FMC – ACE/TCM/PART/0252 & NSEL MEMBER - 14120 SEBI- NCDEX - INZ000048620

Copyright © 2017 Arcadia Share & Stock Brokers Pvt. Ltd.

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

GO TO TOP
CLOSE X
Exclusive Email address for the Customer Grievance dphelp@arcadiashare.com
CLOSE

COMPLAINTS FORM